Syros Pharmaceuticals, Inc. (SYRS): Kewajiban jangka cendhak perusahaan

This chart of Syros Pharmaceuticals (SYRS) stock quotes on the GURU.Markets platform, where the metric stands at 0.00, reflects the impact of global logistics and scientific disruptions on drug development timelines. However, the humanitarian status of medicine minimizes sanction risks, ensuring stable Western partnerships. The business foundation relies on a robust patent portfolio and strategic alliances that support capital until the company becomes a cash generator.

Short-term liability dynamics serve as a key liquidity indicator, determining the issuer's ability to service debts within a year without compromising operational stability. By analyzing the short-term debt trajectory, an investor assesses the financial leverage of Syros Pharmaceuticals (SYRS), which funds external CROs for genomic testing, balancing investments in innovation against credit load risks.